Advertisement
Product Releases
Advertisement

Barrier Gauze Wound Dressings

Wed, 02/24/2010 - 7:24am

LISTED UNDER:

Derma Sciences, Inc.’s BIOGUARD™ barrier gauze wound dressings have recently been classified by the FDA as Class II medical devices. The newly issued guidance pertains to a wound dressing with permanently bound cationic biocide polyDADMAC, one of the molecular entities covered in nine Quick-Med U.S. patents/patents pending and in 24 foreign counterparts.

Derma Sciences, Inc.’s BIOGUARD™ barrier gauze wound dressings have recently been classified by the FDA as Class II medical devices. The newly issued guidance pertains to a wound dressing with permanently bound cationic biocide polyDADMAC, one of the molecular entities covered in nine Quick-Med U.S. patents/patents pending and in 24 foreign counterparts.

According to the company, BIOGUARD dressings feature:

  • The ability for the dressings to serve as a barrier to infection, kill germs absorbed into the dressing and provide an optimum wound healing environment.
  • An active agent that maintains effectiveness even in the presence of large amounts of wound fluid.
  • A non-leaching antimicrobial wound dressing, while other antimicrobial dressings rely on the release of chemicals to the wound bed, could cause the formation of resistant bacterial strains.
  • Ideal use as prophylactic infection control dressings, especially in the hospital environment, where deaths related to hospital-acquired infections have risen to become the fourth leading cause of death in the U.S. after heart disease, automobile accidents and cancer.

For more information, visit www.dermasciences.com

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading